🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

That’s a wrap on #EHC2024! Through insightful discussions & exciting collaborations, we’re excited to continue our work to accelerate access to care and diagnosis for #migraine & help drive change for women globally. European Headache Federation #MigraineAwareness #Access2Care

#NEWS: The U.S. FDA has approved our treatment for #AtopicDermatitis (AD). Read more: ogn.llc/6016opI90

2024 was filled with community engagement, progress & opportunity to improve health care for women globally. As we head into 2025, we’re taking the most important things with us into the new year to continue to work to improve the health of women. #2025Predictions #WomensHealth

From all of us at Organon, we hope everyone has a safe and joyous holiday season! #HappyHolidays

Per the @GreenJrnl & NCBI, U.S. maternal morbidity rates are rising, w/ postpartum hemorrhage (PPH) as the leading cause. Organon is educating on the importance of timely medical intervention & treatment options to minimize birth complications. Visit us at #SMFM2025, booth 1223.

Organon’s #HerPromise grants help organizations make a difference in the world. With Organon's support, Ella Es Astronauta is providing education to young girls from vulnerable areas in Latin America, empowering them to speak up & advocate for themselves: ogn.llc/6015UNSGH

We’re closed in honor of International Women’s Day, providing our employees with this holiday to recommit to their health and well-being. #IWD2025 #IWD #AccelerateAction #Organon #WomensHistoryMonth

A new analysis of Phase 3 data for our recently-approved topical therapy for atopic dermatitis (eczema) has been presented at #AAD2025. Read the press release to learn more: ogn.llc/6019qJxbR

Announcing that Organon has joined EMHA- European Migraine and Headache Alliance as a Migraine Friendly Workplace, bolstering our commitment to improve understanding of #migraine and its impact, and help those affected achieve a better every day. Learn more about migraine: ogn.llc/6015qVRHc

Caring for a child with eczema can have its fair share of challenges. Watch as Jaylin shares her journey in navigating her daughter’s eczema diagnosis and how finding education, support, and community helped them both thrive. #EczemaAwareness #Eczema #Dermatology

Today, we announced with Shanghai Henlius that the European Medicines Agency has validated the Marketing Authorization Application for an investigational #biosimilar. Read the #news: ogn.llc/6011qYBnt

#NEWS: Organon announced today that it has acquired regulatory and commercial rights in the U.S. for a #biosimilar product that complements our existing business, expanding our immunology portfolio with a multi-indication #arthritis treatment. Read the news:

Organon is dedicated to closing the gender data gap. Our project w/ Fundación Gaspar Casal, the Spanish Health Atlas w/ Perspective, uses data to promote equitable health decisions. Working w/ like-minded partners & innovators, we aim to deliver a new era in healthcare. Organon España

#Biosimilars may expand access to biologic treatments and lower costs to the health care system, but certain barriers have slowed adoption in the U.S. Learn more from health economist James Chambers, James Chambers of Tufts Medical Center in this interview with The Medicine Maker. Read

#MothersDay is a moment to celebrate all the moms and mother figures in our lives. Today is a reminder that it is vital to create a world where we value every stage of motherhood and every definition of “mom.” #HappyMothersDay

The FDA has granted #interchangeability designation to Samsung Bioepis and Organon for one of our #biosimilars, letting pharmacists substitute a biosimilar without a new Rx, subject to state law, potentially making medication more accessible for patients. Learn more:

#News Organon and Evvy are collaborating to help offer a patient-first experience for women suffering from #BacterialVaginosis (BV), the most common vaginal condition in women of reproductive age in the US, affecting approximately 21 million women. Together, we aim to help women

Fathers play a critical role in supporting women’s health. Even small, everyday actions like buying tampons or having open conversations about mental and sexual health can help eliminate stigma and empower daughters. #HappyFathersDay